Stemedica Initiating Ph IIb/III Trial for Patients with Chronic Ischemic Stroke
19 Jan 2023 //
BUSINESSWIRE
StemProtein receives US patent for biodegradable microneedle device
24 Aug 2021 //
PHARMABIZ
19 Jan 2023 //
BUSINESSWIRE
24 Aug 2021 //
PHARMABIZ